Overview

Clinical images

Request more info Get a quote

Overview

Clinical images

Request more info Get a quote

SIGNA™ 7T MRI scanner*

With UltraG gradients, the SIGNA™ 7T MRI scanner delivers superior contrast and SNR performance for improved diagnostic confidence, all with familiar state-of-the-art applications.

At a glance

Advanced technology

GE HealthCare’s most powerful whole-body gradient platform to date

State-of-the-art applications

Freedom and familiarity

Same look and feel as other GE HealthCare MRI scanners, for research or clinical use

7T MRI scanner: scientific discovery meets clinical translation

Designed to overcome the limitations for many of today’s clinical MR systems, the SIGNA™ 7T is a powerful new platform for advancing neurological research and clinical translation. Approximately five times more powerful than most clinical systems, SIGNA™ 7T is designed to detect subtle structures that may be significant for clinicians and researchers alike. Boost advanced applications with GE HealthCare's most powerful whole-body gradient platform to date, delivering exceptional resolution and contrast-to-noise ratio.

Clinical images

Bringing together the power of UltraG gradients and our SIGNA 7T MRI scanner

Our SIGNA 7T MRI scanner is primarily intended for brain imaging as well as imaging of extremities, such as the knee. It delivers impressive results with diffusion tensor imaging (DTI) and functional MRI (fMRI) studies for advanced clinical and research scanning.

See all clinical images

SIGNA 7T MRI scan using AIR recon DL and a Nova head coil

SIGNA 7T MRI scan using Diffusion Tensor Imaging acquired with AIR™ Recon DL

SIGNA 7T MRI scan; resting state fMRI

SIGNA 7T MRI scan; patella cartilage. Axial PD fat sat with AIR™ Recon DL

SIGNA 7T MRI scan using AIR recon DL and a Nova head coil
SIGNA 7T MRI scan using Diffusion Tensor Imaging acquired with AIR™ Recon DL
SIGNA 7T MRI scan; resting state fMRI
SIGNA 7T MRI scan; patella cartilage. Axial PD fat sat with AIR™ Recon DL

“The SIGNA 7.0T has allowed us to explore²³Na concentration changes associated with glioblastomas as well as response to ECT therapy for the treatment of depression”

Vince A. Magnotta, PhD

Director of the MR Research Facility and Professor of Radiology – Division of Neuroradiology University of Iowa, USA

Download brochure

Vince A. Magnotta, PhD

Benefits

SIGNA™ 7T MRI scanner - it’s where scientific discovery meets clinical translation

Our SIGNA 7T combines innovative hardware with state-of-the-art software for overcoming common challenges with operating at ultra high fields.

Uncover new contrasts, such as Quantitative Susceptibility Mapping (QSM), for advancing neurological disorder research. Explore novel biomarkers for ischemic stroke characterization and uncover subtle structures with ultra-high resolution imaging with our SIGNA 7T platform.

SIGNA 7T powered by a common suite of SIGNA Imaging Applications

Users have access to our latest state-of-the-art applications along with deep-learning tools like AIR x™ Brain and Knee as well as AIR™ Recon DL, while delivering the diagnostic confidence of an ultra-high-field system.

signa-7t-mri-scanner-feature-hero-1-ci-en

UltraG Gradients to power your research

Our 7T MRI scanner is GE HealthCare’s most powerful whole-body gradient system yet. With peak amplitude of 113 mT/m and a peak slew rate of 260 T/m/s, this scanner can properly leverage the clinical capabilities and research demands that users expect from a 7T.

SIGNA 7T freedom and familarity

Users can switch between clinical and research modes for easy protocol deployment. Our SIGNA 7T scanner share the same state-of-the-art software platform as GE HealthCare 1.5T and 3T product portfolio, enhancing ease of use and productivity

signa-7t-mri-scanner-feature-hero-3-st-en

“In addition to an extensive 7T research program, the clinical protocols on our SIGNA 7T MRI scanner in Pisa include epilepsy, Parkinson’s and white matter diseases. We find susceptibility-weighted imaging, and the potential for quantitative susceptibility mapping, an indispensable tool for better delineation of microscopic brain features to provide insights on such conditions as neuronal tumor, focal cortical dysplasia and polymicrogyria.”

Michela Tosetti, PhD

Director of Medical Physics and MR Lab IRCCS Stella Maris Scientific Institute and IMAGO7 Research Centre, Tuscany Italy